India  

Novavax

Swedish clinical-stage vaccine company

Novavax    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Novavax, Inc. is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden. As of 2020, it has an ongoing Phase III clinical trial in older adults for its candidate vaccine for seasonal influenza, NanoFlu and a candidate vaccine for prevention of COVID-19.

0
shares
ShareTweetSavePostSend
 

Novavax Coronavirus Vaccine Phase 1 Data Shows Promise [Video]

Novavax Coronavirus Vaccine Phase 1 Data Shows Promise

A third US company has released research data showing its coronavirus vaccine is safe and elicits an immune response. According to CNN, Novavax, Inc. released Phase 1 results on Tuesday. The data shows..

Credit: Wochit News     Duration: 00:32Published
Novavax COVID-19 vaccine produces antibodies in small study [Video]

Novavax COVID-19 vaccine produces antibodies in small study

Maryland-based biotechnology company, Novavax, said on Tuesday its experimental COVID-19 vaccine produced antibodies against the novel coronavirus and appears to be safe, according to an early-stage..

Credit: Reuters Studio     Duration: 00:49Published
U.S. hands Novavax $1.6b to work on COVID-19 vaccine [Video]

U.S. hands Novavax $1.6b to work on COVID-19 vaccine

The U.S. government awarded $1.6 billion to help Novavax quickly come up with a potential novel coronavirus vaccine, sending the stock surging more than 30 percent. Conway G. Gittens has more.

Credit: Reuters Studio     Duration: 02:12Published

You Might Like

No news matches found

Sorry, we were unable to find any results in our database for your query


Free news archive access


Did you know?
You are eligible to search our news archive with millions of news references free of charge.

To do this, please sign in first at the top of the screen.

Information about free access to our news archive


Search this site and the web:


Free news archive